Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 14;43(3):259-264.
doi: 10.3760/cma.j.issn.0253-2727.2022.03.014.

[Advances in long-acting recombinant factor Ⅸ for the treatment of hemophilia B]

[Article in Chinese]
X Y Wang  1 , R C Yang  1
Affiliations

[Advances in long-acting recombinant factor Ⅸ for the treatment of hemophilia B]

[Article in Chinese]
X Y Wang et al. Zhonghua Xue Ye Xue Za Zhi. .
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Srivastava A, Santagostino E, Dougall A, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition[J] Haemophilia. 2020;26 Suppl 6:1–158. doi: 10.1111/hae.14046. - DOI - PubMed
    1. 中华医学会血液学分会血栓与止血学组, 中国血友病协作组. 血友病治疗中国指南(2020年版)[J] 中华血液学杂志. 2020;41(4):265–271. doi: 10.3760/cma.j.issn.0253-2727.2020.04.001. - DOI - PubMed
    1. Shapiro A. Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia[J] Expert Opin Biol Ther. 2013;13(9):1287–1297. doi: 10.1517/14712598.2013.819339. - DOI - PubMed
    1. 孙 博洋, 杨 仁池. 血友病治疗新进展[J] 中华血液学杂志. 2018;39(10):873–876. doi: 10.3760/cma.j.issn.0253-2727.2018.10.018. - DOI - PMC - PubMed
    1. Pasi KJ, Lissitchkov T, Mamonov V, et al. Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort[J] J Thromb Haemost. 2021;19(6):1436–1446. doi: 10.1111/jth.15270. - DOI - PMC - PubMed